Crispr Therapeutics: Lucrative Partnerships And Promising Data Increase Its AppealSeeking Alpha • 08/28/21
Earnings Growth & Price Strength Make CRISPR Therapeutics AG (CRSP) a Stock to WatchZacks Investment Research • 08/24/21
CRISPR Therapeutics AG (CRSP) Tops Q2 Earnings and Revenue EstimatesZacks Investment Research • 07/29/21
CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial ResultsGlobeNewsWire • 07/29/21
CRISPR Therapeutics AG (CRSP) to Report Q2 Results: Wall Street Expects Earnings GrowthZacks Investment Research • 07/19/21
CRISPR Therapeutics AG (CRSP) Stock Moves -0.67%: What You Should KnowZacks Investment Research • 07/16/21
Why CRISPR Therapeutics, Editas Medicine, and Beam Therapeutics Dropped This WeekThe Motley Fool • 07/16/21